Saccadous is an early stage startup based in Scottsdale, Arizona. Leveraging patented technology, Saccadous specializes in the identification and assessment of neurological disorders such as Parkinson's, Alzheimer's, and Traumatic Brain Injury (TBI). Their innovative solution analyzes unique and microscopic eye movements, known as microsaccades, to detect and track these conditions in a transformative, non-invasive manner.

For Parkinson's disease, Saccadous focuses on studying eye movements including fixational movements and square-wave jerks, providing valuable insights into the stage and progression of the disease. In the case of Alzheimer's, their analysis of eye signatures aims to reveal indicators earlier in the aging process, thereby optimizing early intervention for patients. Furthermore, Saccadous employs eye movement tests for Traumatic Brain Injury, enabling physicians to swiftly diagnose and continually assess patients throughout their recovery.

Please note that Saccadous's technology and products have not yet been evaluated by the FDA and are not currently available to the general public. To gain more understanding of their research and ongoing efforts, you can reach out to them via email